These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 3389739

  • 1. Evidence for a novel binding site for the synthetic progestogen, gestodene on oestrogen receptor in human malignant tissue.
    Iqbal MJ, Valyani SH.
    Anticancer Res; 1988; 8(3):351-4. PubMed ID: 3389739
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of gestodene binding to the oestrogen receptor in human malignant breast tissue.
    Iqbal MJ, Colletta AA.
    Anticancer Res; 1987; 7(1):45-8. PubMed ID: 3566182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel binding site for a synthetic progestagen in breast cancer cells.
    Colletta AA, Howell FV, Baum M.
    J Steroid Biochem; 1989 Dec; 33(6):1055-61. PubMed ID: 2615351
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Calmodulin decreases the estrogen binding capacity of the estrogen receptor.
    Bouhoute A, Leclercq G.
    Biochem Biophys Res Commun; 1996 Oct 23; 227(3):651-7. PubMed ID: 8885989
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE, Polin LA, Palomino E, Brooks SC.
    J Med Chem; 1997 Oct 24; 40(22):3659-69. PubMed ID: 9357533
    [Abstract] [Full Text] [Related]

  • 10. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
    Carlson KE, Choi I, Gee A, Katzenellenbogen BS, Katzenellenbogen JA.
    Biochemistry; 1997 Dec 02; 36(48):14897-905. PubMed ID: 9398213
    [Abstract] [Full Text] [Related]

  • 11. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS, Markaverich BM, Clark JH, Panko WB.
    Cancer Res; 1982 Nov 02; 42(11):4449-54. PubMed ID: 7127287
    [Abstract] [Full Text] [Related]

  • 12. Gestodene: a novel synthetic progestin--characterization of binding to receptor and serum proteins.
    Pollow K, Juchem M, Grill HJ, Elger W, Beier S, Henderson D, Schmidt-Gollwitzer K, Manz B.
    Contraception; 1989 Sep 02; 40(3):325-41. PubMed ID: 2548807
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun 02; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 02; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 17. Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?
    Speirs V.
    J Pathol; 2002 Jun 02; 197(2):143-7. PubMed ID: 12015736
    [Abstract] [Full Text] [Related]

  • 18. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice.
    Kubota T, Ishibiki K, Abe O, Kosano H, Ohsawa N, Hoffman RM.
    Anticancer Res; 1993 Jun 02; 13(4):935-40. PubMed ID: 8352562
    [Abstract] [Full Text] [Related]

  • 19. Nuclear estradiol-binding sites in human breast cancer.
    Vandewalle B, Peyrat JP, Bonneterre J, Hecquet B, Dewailly D, Lefebvre J.
    Cancer Res; 1983 Sep 02; 43(9):4497-503. PubMed ID: 6683589
    [Abstract] [Full Text] [Related]

  • 20. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites.
    Lemus AE, Zaga V, Santillán R, García GA, Grillasca I, Damián-Matsumura P, Jackson KJ, Cooney AJ, Larrea F, Pérez-Palacios G.
    J Endocrinol; 2000 Jun 02; 165(3):693-702. PubMed ID: 10828854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.